Crusade Risk Score for ACS at App Store analyse

App power index: 156 (based on ranks around App Stores today)
Health & Fitness Medical
Developer: Putu Angga Risky Raharja
Price: 0 free
Current version: 3.1, last update: 1 year ago
First release : 31 May 2017
App size: 36.05 Mb
4.0 ( 960 ratings )
follow app

Estimation application downloads and cost

> 3.43k
Monthly downloads
~ $ 1.4k
Estimation App Cost


Coronary heart disease (CHD) is one of the most important leading causes of death in the whole world. Among the different clinical presentations of Coronary heart disease (CHD), acute coronary syndrome (ACS) is the most important and life threatening condition. In spite of their obvious effect, antithrombotic therapies for acute coronary syndrome (ACS) significantly increase bleeding. Hence, it is important to predict the bleeding risk in acute coronary syndrome (ACS) patients in order to modify their treatment aiming to reduce their bleeding events and improve their outcome. "CRUSADE Risk Score for ACS: Cardiology Calculator" apps will help to stratify bleeding risk in acute coronary syndrome (ACS) patients with CRUSADE score.

Why should you choose "CRUSADE Risk Score for ACS: Cardiology Calculator"?
- Simple and very easy to use.
- Define the importance of CRUSADE bleeding risk stratification
- Accurately scoring all the variables needed
- Thorough interpretation of the bleeding risk for every patient
- Calculates not only the risk of major bleeding in general non-ST elevation acute coronary syndrome (NSTE-ACS) patients but also the relation to the number of anti-thrombotics used and the relation to the treatment approach (whether it will be conservative or interventional)
- It is totally free. Download now!

CRUSADE Risk Score for acute coronary syndrome (ACS) is a scoring system used to stratify the risk of bleeding in patients with NSTE-ACS (Non-ST Elevation Acute Coronary Syndrome) in relation to the use of anti-thrombotics. CRUSADE bleeding score was developed and validated in a large community-treated NSTEMI patients. Clinical trials involving almost 48.000 patients with NSTEMI have demonstrated that major bleeding is associated with a 5-fold increase in 30-day mortality. This makes bleeding-risk stratification is a routine part in NSTE-ACS patients investigation. Download "CRUSADE Risk Score for ACS: Cardiology Calculator" app now!

Disclaimer: all calculations must be re-checked and should not be used alone to guide patient care, nor should they substitute for clinical judgment. Calculations in this "CRUSADE Risk Score for ACS: Cardiology Calculator" app might be different with your local practice. Consult to expert doctor whenever necessary.
Read more
No search terms founded
Available in countries
Country Price
Canada free
China free
France free
Germany free
Italy free
Netherlands free
Portugal free
Spain free
UK free
India free
Japan free
Korea, Republic Of free
Poland free
Russia free
Turkey free
USA free
Korea, Republic Of free
Ukraine free
Available for devices
iPad2Wifi, iPad23G, iPhone4S, iPadThirdGen, iPadThirdGen4G, iPhone5, iPodTouchFifthGen, iPadFourthGen, iPadFourthGen4G, iPadMini, iPadMini4G, iPhone5c, iPhone5s, iPadAir, iPadAirCellular, iPadMiniRetina, iPadMiniRetinaCellular, iPhone6, iPhone6Plus, iPadAir2, iPadAir2Cellular, iPadMini3, iPadMini3Cellular, iPodTouchSixthGen, iPhone6s, iPhone6sPlus, iPadMini4, iPadMini4Cellular, iPadPro, iPadProCellular, iPadPro97, iPadPro97Cellular, iPhoneSE, iPhone7, iPhone7Plus, iPad611, iPad612, iPad71, iPad72, iPad73, iPad74, iPhone8, iPhone8Plus, iPhoneX, iPad75, iPad76, iPhoneXS, iPhoneXSMax, iPhoneXR, iPad812, iPad834, iPad856, iPad878, iPadMini5, iPadMini5Cellular, iPadAir3, iPadAir3Cellular, iPodTouchSeventhGen, iPhone11, iPhone11Pro, iPadSeventhGen, iPadSeventhGenCellular, iPhone11ProMax, iPhoneSESecondGen, iPadProSecondGen, iPadProSecondGenCellular, iPadProFourthGen, iPadProFourthGenCellular,